The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skin
Open accessAbstract
The peptide substance P (SP) has been implicated in inflammatory conditions, such as psoriasis, where mast cells and VEGF are increased. A relationship between SP and VEGF has not been well studied, nor has any interaction with the proinflammatory cytokines, especially IL-33. Here we report that SP (0.1–10 μM) induces gene expression and secretion of VEGF from human LAD2 mast cells and human umbilical core blood-derived cultured mast cells (hCBMCs). This effect is significantly increased by coadministration of IL-33 (5–100 ng/mL) in both cell types. The effect of SP on VEGF release is inhibited by treatment with the NK-1 receptor antagonist 733,060. SP rapidly increases cytosolic calcium, and so does IL-33 to a smaller extent; the addition of IL-33 augments the calcium increase. SP-induced VEGF production involves calcium-dependent PKC isoforms, as well as the ERK and JNK MAPKs. Gene expression of IL-33 and histidine decarboxylase (HDC), an indicator of mast cell presence/activation, is significantly increased in affected and unaffected (at least 15 cm away from the lesion) psoriatic skin, as compared with normal control skin. Immunohistochemistry indicates that IL-33 is associated with endothelial cells in both the unaffected and affected sites, but is stronger and also associated with immune cells in the affected site. These results imply that functional interactions among SP, IL-33, and mast cells leading to VEGF release contribute to inflammatory conditions, such as the psoriasis, a nonallergic hyperproliferative skin inflammatory disorder with a neurogenic component.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: The cytokine interleukin-33 mediates anaphylactic shock
Pushparaj, P. N., Tay, H. K., H'ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. Y., & Melendez, A. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901206106 · Cited by 285
RetractedDérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,596
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Moussion, C., Ortega, N., & Girard, J.-P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003331 · Cited by 1,179
Schön, M. P., & Boehncke, W.-H. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041320 · Cited by 955
The role of substance P in inflammatory disease
O'Connor, T. M., O'Connell, J., O'Brien, D. I., Goode, T., Bredin, C. P., & Shanahan, F. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20061 · Cited by 789
Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)
Byrne, A. M., Bouchier-Hayes, D. J., & Harmey, J. H. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00379.x · Cited by 744
Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B., & Dvorak, H. F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1141 · Cited by 685
Kirshenbaum, A. S., Akin, C., Wu, Y., Rottem, M., Goff, J. P., Beaven, M. A., Rao, V. K., & Metcalfe, D. D. (2003) · Leukemia Research · doi:10.1016/s0145-2126(02)00343-0 · Cited by 510
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Xu, D., Jiang, H.-R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N., Kurowska-Stolarska, M., McKenzie, A. N. J., McInnes, I. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801898105 · Cited by 464
Mousli, M., Bueb, J., Bronner, C., Rouot, B., & Landry, Y. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90179-c · Cited by 454
Theoharides, T. C., Singh, L. K., Boucher, W. S., Pang, X., Létourneau, R., Webster, E., & Chrousos, G. P. (1998) · Endocrinology · doi:10.1210/en.139.1.403 · Cited by 447
Self-citationCritical role of mast cells in inflammatory diseases and the effect of acute stress
Theoharides, T. C., & Cochrane, D. E. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.041 · Cited by 436
Self-citationAngiogenesis drives psoriasis pathogenesis
Heidenreich, R., Röcken, M., & Ghoreschi, K. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00669.x · Cited by 383
Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors
Tatemoto, K., Nozaki, Y., Tsuda, R., Konno, S., Tomura, K., Furuno, M., Ogasawara, H., Edamura, K., Takagi, H., Iwamura, H., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.177 · Cited by 382
IL-33 can promote survival, adhesion and cytokine production in human mast cells
Iikura, M., Suto, H., Kajiwara, N., Oboki, K., Ohno, T., Okayama, Y., Saito, H., Galli, S. J., & Nakae, S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700663 · Cited by 370
Xia, Y.-P., Li, B., Hylton, D., Detmar, M., Yancopoulos, G. D., & Rudge, J. S. (2003) · Blood · doi:10.1182/blood-2002-12-3793 · Cited by 367
Neuroimmunoendocrine circuitry of the ‘brain-skin connection’
Paus, R., Theoharides, T. C., & Arck, P. C. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.10.002 · Cited by 343
Self-citationGrützkau, A., Krüger-Krasagakes, S., Baumeister, H., Schwarz, C., Kögel, H., Welker, P., Lippert, U., Henz, B. M., & Möller, A. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.4.875 · Cited by 337
Boesiger, J., Tsai, M., Maurer, M., Yamaguchi, M., Brown, L. F., Claffey, K. P., Dvorak, H. F., & Galli, S. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1135 · Cited by 336
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells
Moulin, D., Donzé, O., Talabot-Ayer, D., Mézin, F., Palmer, G., & Gabay, C. (2007) · Cytokine · doi:10.1016/j.cyto.2007.09.013 · Cited by 309
Direct activation of GTP‐binding regulatory proteins (G‐proteins) by substance P and compound 48/80
Mousli, M., Bronner, C., Landry, Y., Bockaert, J., & Rouot, B. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80023-c · Cited by 299
Cao, J., Papadopoulou, N., Kempuraj, D., Boucher, W. S., Sugimoto, K., Cetrulo, C. L., & Theoharides, T. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7665 · Cited by 285
Self-citationIL-33 induces IL-13 production by mouse mast cells independently of IgE-FcεRI signals
Ho, L. H., Ohno, T., Oboki, K., Kajiwara, N., Suto, H., Iikura, M., Okayama, Y., Akira, S., Saito, H., Galli, S. J., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407200 · Cited by 285
Stress, symmetry, and psoriasis: Possible role of neuropeptides
Farber, E. M., Nickoloff, B. J., Recht, B., & Fraki, J. E. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70034-0 · Cited by 261
AL'ABADIE, M. S., KENT, G. G., & GAWKRODGER, D. J. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb02900.x · Cited by 261
Psychologic Factors in Psoriasis: Consequences, Mechanisms, and Interventions
Fortune, D. G., Richards, H. L., & Griffiths, C. E. M. (2005) · Dermatologic Clinics · doi:10.1016/j.det.2005.05.022 · Cited by 244
Frost, J. A., Geppert, T. D., Cobb, M. H., & Feramisco, J. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3844 · Cited by 218
Activation of rat peritoneal mast cells by substance P and mastoparan.
Mousli, M., Bronner, C., Bueb, J. L., Tschirhart, E., Gies, J. P., & Landry, Y. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21370-2 · Cited by 197
Nakamura, M., Toyoda, M., & Morohashi, M. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05586.x · Cited by 197
Direct Neurite-Mast Cell Communication In Vitro Occurs Via the Neuropeptide Substance P
Suzuki, R., Furuno, T., McKay, D. M., Wolvers, D., Teshima, R., Nakanishi, M., & Bienenstock, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2410 · Cited by 195
Substance P induces granulocyte infiltration through degranulation of mast cells.
Matsuda, H., Kawakita, K., Kiso, Y., Nakano, T., & Kitamura, Y. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.3.927 · Cited by 194
Bhushan, M., McLaughlin, B., Weiss, J. B., & Griffiths, C. E. M. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03205.x · Cited by 187
Single-Nucleotide Polymorphisms of Vascular Endothelial Growth Factor in Psoriasis of Early Onset
Young, H. S., Bhushan, M., Griffiths, C. E. M., Summers, A., & Brenchley, P. E. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.22107.x · Cited by 170
Pavlovic, S., Daniltchenko, M., Tobin, D. J., Hagen, E., Hunt, S. P., Klapp, B. F., Arck, P., & Peters, E. M. J. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701079 · Cited by 168
Salvén, P., Hattori, K., Heissig, B., & Rafii, S. (2002) · The FASEB Journal · doi:10.1096/fj.02-0134fje · Cited by 161
Electron microscopical evidence for a direct contact between nerve fibres and mast cells
Wiesner-Menzel, L., Schulz, B., Vakilzadeh, F., & Czarnetzki, B. (1981) · Acta Dermato-Venereologica · doi:10.2340/0001555561465469 · Cited by 158
G protein-dependent activation of mast cell by peptides and basic secretagogues
Ferry, X., Brehin, S., Kamel, R., & Landry, Y. (2002) · Peptides · doi:10.1016/s0196-9781(02)00090-6 · Cited by 150
The role of neuropeptides in psoriasis
Saraceno, R., Kleyn, C. E., Terenghi, G., & Griffiths, C. E. M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07518.x · Cited by 145
Silver, M. R., Margulis, A. R., Wood, N. L., Goldman, S. J., Kasaian, M. T., & Chaudhary, D. (2009) · Inflammation Research · doi:10.1007/s00011-009-0088-5 · Cited by 130
Jung, Y. D., Liu, W., Reinmuth, N., Ahmad, S. A., Fan, F., Gallick, G. E., & Ellis, L. M. (2001) · Angiogenesis · doi:10.1023/a:1012291524723 · Cited by 115
Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin
Peters, E. M. J., Kuhlmei, A., Tobin, D. J., Müller‐Röver, S., Klapp, B. F., & Arck, P. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.08.005 · Cited by 115
Mast cell mediators in allergic inflammation and mastocytosis
Castells, M. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.005 · Cited by 112
Characterization of Mast Cell-Committed Progenitors Present in Human Umbilical Cord Blood
Kempuraj, D., Saito, H., Kaneko, A., Fukagawa, K., Nakayama, M., Toru, H., Tomikawa, M., Tachimoto, H., Ebisawa, M., Akasawa, A., et al. (1999) · Blood · doi:10.1182/blood.v93.10.3338.410k05_3338_3346 · Cited by 110
Self-citationKawakami, Y., Hartman, S. E., Holland, P. M., Cooper, J. A., & Kawakami, T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1795 · Cited by 106
Remröd, C., Lonne‐Rahm, S., & Nordlind, K. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-007-0745-x · Cited by 98
Naukkarinen, A., Harvima, I. T., Paukkonen, K., Aalto, M.-L., & Horsmanheimo, M. (1993) · Archives of Dermatological Research · doi:10.1007/bf00371834 · Cited by 98
Chan, J., Smoller, B. R., Raychaudhuri, S. P., Raychaudhuri, S. P., Farber, E. M., & Chan, C. K. F. (1997) · Archives of Dermatological Research · doi:10.1007/s004030050249 · Cited by 89
Paus, R., Heinzelmann, T., Robicsek, S. A., Czarnetzki, B. M., & Maurer, M. (1995) · Archives of Dermatological Research · doi:10.1007/bf00373436 · Cited by 88
Simonetti, O., Lucarini, G., Goteri, G., Zizzi, A., Biagini, G., Muzio, L. L., & Offidani, A. M. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200601900405 · Cited by 87
Lee, C.-C., Chen, S.-C., Tsai, S.-C., Wang, B.-W., Liu, Y.-C., Lee, H.-M., & Shyu, K. (2005) · Journal of Biomedical Science · doi:10.1007/s11373-005-9037-7 · Cited by 82
Association of Cutaneous Mast Cells and Sensory Nerves with Psychic Stress in Psoriasis
Harvima, I. T., Viinamäki, H. T., Naukkarinen, A., Paukkonen, K., Neittaanmäki, H., Harvima, R. J., & Horsmanheimo, M. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000288690 · Cited by 77
QUANTITATIVE HISTOCHEMICAL ANALYSIS OF MAST CELLS AND SENSORY NERVES IN PSORIATIC SKIN
Naukkarinen, A., Järvikallio, A., Lakkakorpi, J., Harvima, I. T., Harvima, R. J., & Horsmanheimo, M. (1996) · The Journal of Pathology · Cited by 75
Plasma concentration of selected neuropeptides in patients suffering from psoriasis
Reich, A., Orda, A., Wiśnicka, B., & Szepietowski, J. C. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00544.x · Cited by 75
Kandere‐Grzybowska, K., Gheorghe, D., Priller, J., Esposito, P., Huang, M., Gerard, N. P., & Theoharides, T. C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02975-5 · Cited by 73
Self-citationNeuropeptides and general neuronal marker in psoriasis an immunohistochemical study
Al'Abadie, M. S. K., Senior, H. J., BLEEHEN, S. S., & Gawkrodger, D. J. (1995) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1995.tb01354.x · Cited by 72
Endogenous histamine excites neurones in the guinea‐pig superior cervical ganglion in vitro.
Christian, E. P., Undem, B. J., & Weinreich, D. M. (1989) · The Journal of Physiology · doi:10.1113/jphysiol.1989.sp017498 · Cited by 70
Seabrook, G. R., Shepheard, S. L., Williamson, D. J., Tyrer, P. J., Rigby, M., Cascieri, M. A., Harrison, T., Hargreaves, R. J., & Hill, R. G. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00706-6 · Cited by 65
Association of psychic stress with clinical severity and symptoms of psoriatic patients.
Harvima, R. J., Viinamäki, H. T., Harvima, I., Naukkarinen, A., Savolainen, L., Aalto, M.-L., & Horsmanheimo, M. (1996) · Acta Dermato Venereologica · doi:10.2340/0001555576467471 · Cited by 59
Evidence for Vascular Endothelial Growth Factor (VEGF) as a Modifier Gene in Psoriasis
Detmar, M. J. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.22140.x · Cited by 58
Role of substance P in stress-derived degranulation of dermal mast cells in mice
Kawana, S., Liang, Z., Nagano, M., et al. (2006) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.12.004 · Cited by 56
Presence of NK1receptors on a mucosal-like mast cell line, RBL-2H3 cells
Cooke, H. J., Fox, P., Alferes, L., Fox, C. C., & Wolfe, S. A. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y98-014 · Cited by 53
Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis
Barile, S., Medda, E., Nisticò, L., Bordignon, V., Cordiali‐Fei, P., Carducci, M., Rainaldi, A., Marinelli, R., & Bonifati, C. (2006) · Experimental Dermatology · doi:10.1111/j.0906-6705.2006.00416.x · Cited by 48
Zhang, C., Hirasawa, N., & Beaven, M. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4968 · Cited by 38
Özdamar, Ş. O., Seçkin, D., Kandemır, B., et al. (2009) · Dermatology · doi:10.1159/000246359 · Cited by 35
Substance P: an historical perspective
Leeman, S. E., & Ferguson, S. (2000) · Neuropeptides · doi:10.1054/npep.2000.0826 · Cited by 31
Self-citationThe latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator.
Ml, C., Kempuraj, D., Salini, V., Vecchiet, J., Tetè, S., Ciampoli, C., Conti, F., Cerulli, G. G., Caraffa, A., Antinolfi, P., et al. (2009) · PubMed · Cited by 28
Self-citationNK-1 antagonist CP99994 inhibits stress-induced mast cell degranulation in rats
Erin, N., Ersoy, Y., Ercan, F., Akıcı, A., & Oktay, Ş. (2004) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2004.01613.x · Cited by 28
Tokuda, M., Miyamoto, R., Sakuta, T., Nagaoka, S., & Torii, M. (2005) · Connective Tissue Research · doi:10.1080/03008200500182490 · Cited by 27
Cited by
Mast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Theoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.014 · Cited by 680
Self-citationMast Cells, Mastocytosis, and Related Disorders
Theoharides, T. C., Valent, P., & Akin, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1409760 · Cited by 518
Self-citationRole of IL-33 in inflammation and disease
Miller, A. M. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-22 · Cited by 481
Imai, Y., Yasuda, K., Sakaguchi, Y., Haneda, T., Mizutani, H., Yoshimoto, T., Nakanishi, K., & Yamanishi, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307321110 · Cited by 431
Metadata
- Authors
- Theoharides, T. C., Zhang, B., Kempuraj, D., Tagen, M., Vasiadi, M., Angelidou, A., Alysandratos, K.-D., Kalogeromitros, D., Asadi, S., Stavrianeas, N., Peterson, E., Leeman, S., & Conti, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-02-16
- Volume
- 107
- Issue
- 9
- Pages
- 4448-4453
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2169362733
- Cited by
- 318
- References
- 71
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.